Andrey Kozlov
Fondatore presso 4BIO Ventures Management Ltd.
Provenienza dei contatti di primo grado di Andrey Kozlov
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom.
21
| Holding Company | Investment Managers | 21 |
University of Hamburg
12
| College/University | Other Consumer Services | 12 |
Ascend Gene & Cell Therapies Ltd.
 Ascend Gene & Cell Therapies Ltd. Miscellaneous Commercial ServicesCommercial Services Ascend Gene & Cell Therapies Ltd. is a gene and cell therapy manufacturing specialist that aims to create effective gene therapies to a world-class standard. The company is based in Altrincham, UK, and has subsidiaries in Germany. The British company focuses on constantly refining and flexing their approach and embracing opportunities to innovate to create therapies that change lives. Ascend has over $130m of funding as expert teams merge. The company has a solid platform that allows their team to do their best work and deliver unwavering quality. Timothy Michael Funnell has been the CEO of the company since 2021.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andrey Kozlov tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Oxford | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Enso Ventures Ltd.
 Enso Ventures Ltd. Investment ManagersFinance Enso Ventures Ltd (Enso Ventures) is an independent venture capital firm founded in 2010 by Nikolay Danilov. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Director of Finance/CFO | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Chairman Director/Board Member | |
| FREENET AG | Specialty Telecommunications | Corporate Officer/Principal Director/Board Member | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Hornet Therapeutics Ltd.
 Hornet Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Hornet Therapeutics Ltd. is a British company founded in 2019 that provides immune cell metabolism and cell therapy for cancer treatment. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Code Biotherapeutics, Inc.
 Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Chief Executive Officer | |
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Investment Managers | Founder Private Equity Investor | |
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| BASLER AG | Electronic Components | Director/Board Member Director/Board Member | |
| Chesterton Suntec International Pte Ltd. | Chief Executive Officer | ||
| UNITED ENGINEERS LIMITED | Real Estate Development | Corporate Officer/Principal | |
| Suntec Investment Pte Ltd. | Chief Operating Officer | ||
| RHT Talentchest Pte. Ltd. | Director/Board Member | ||
| Singapore Institute of Directors | Corporate Officer/Principal | ||
| MARY CHIA HOLDINGS LIMITED | Other Consumer Services | Director/Board Member | |
| Rht Chestertons Pte Ltd. | Chief Executive Officer | ||
| METECH INTERNATIONAL LIMITED | Wholesale Distributors | Director/Board Member | |
| SK JEWELLERY GROUP LIMITED | Specialty Stores | Director/Board Member | |
| Singapore Kindness Movement | Director/Board Member | ||
| Talentchest Consulting Pte Ltd. | Chief Executive Officer | ||
F&L Builders & Construction Pte Ltd.
 F&L Builders & Construction Pte Ltd. Miscellaneous Commercial ServicesCommercial Services F & L Builders & Construction Pte Ltd. operates as a Singaporean management construction company. The private company is based in Singapore, Singapore. | Miscellaneous Commercial Services | Chairman | |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Chief Investment Officer | |
Mercantile Group Ltd. (Private Equity)
 Mercantile Group Ltd. (Private Equity) Investment ManagersFinance Mercantile Group Ltd (Private Equity) (Mercantile Group) is a private equity subsidiary of Mercantile Group (UK) Ltd founded in 2000 by Mohammad Moussa. The firm is headquartered in London. | Investment Managers | Consultant / Advisor | |
| Asia Central Resources Pte Ltd. | Director/Board Member | ||
| Eps Worldwide Training Academy Pte Ltd. | Director/Board Member | ||
| Eps Worldwide Pte Ltd. | Director/Board Member | ||
| SunChest Property Consultants Pte. Ltd. | Founder | ||
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| University of Cambridge | College/University | Graduate Degree | |
AviadoBio Ltd.
 AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Consultant / Advisor | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree | |
| University of California San Diego | College/University | Masters Business Admin | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member | |
| Singapore Institute of International Affairs | Corporate Secretary | ||
| LAFE CORPORATION LIMITED | Real Estate Development | Director/Board Member | |
| RS Advisory & Consulting Pte. Ltd. | Founder | ||
| SMT SCHARF AG | Trucks/Construction/Farm Machinery | Corporate Officer/Principal | |
Carl Zeiss AG
 Carl Zeiss AG Electronic ComponentsElectronic Technology Carl Zeiss AG engages in the development and manufacture of scientific optics technologies and solutions services. Its products and solutions inlcude medical, microscopy, optemetry, industrial metrology spectroscopy, semicondictor technology, camera and film lenses, and simulation solutions planetariums. The company was founded by Carl Zeiss in 1846 and is headquartered in Oberkochen, Germany. | Electronic Components | Director/Board Member | |
Voith GmbH & Co. KGaA
 Voith GmbH & Co. KGaA Industrial MachineryProducer Manufacturing Voith GmbH & Co. KGaA operates as a holding company with interests in paper, fabrics, and hydro power generation. The firm’s principal activities are manufacturing of paper machinery, textile machinery, hydro fluid machinery, and turbo power transmission engineering. Its products and services include automation and digital solutions, drives & transmissions, connection components & couplings, hydropower components, hydraulics, pneumatics, cooling, braking systems and papermaking components. The company was founded in 1867 and is headquartered in Heidenheim, Germany. | Industrial Machinery | Corporate Officer/Principal | |
Axa Corporate Solutions SA
 Axa Corporate Solutions SA Property/Casualty InsuranceFinance Axa Corporate Solutions SA provides client solutions. The firm develops new and emerging markets, focusing on parametric, alternative risk transfer and cyber risks. It specializes in insurance, risk management and risk consulting and claims servicing. The company is headquartered in Paris, France. | Property/Casualty Insurance | Director/Board Member | |
| MIT Sloan School of Management | College/University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Singapore | 20 |
| Regno Unito | 12 |
| Stati Uniti | 12 |
| Germania | 8 |
| Francia | 3 |
Settori
| Finance | 11 |
| Health Technology | 10 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Communications | 3 |
Posizioni
| Director/Board Member | 194 |
| Corporate Officer/Principal | 50 |
| Independent Dir/Board Member | 30 |
| Founder | 23 |
| Chief Executive Officer | 23 |
Contatti più connessi
| Insiders | |
|---|---|
| Jean-Francois Formela | 48 |
| Anthony Evnin | 46 |
| Renée Aguiar-Lucander | 26 |
| Eng Huat Sim | 21 |
| Paul David Goldenheim | 18 |
| Brian McVeigh | 15 |
| Mirja Steinkamp | 13 |
| Gert-Hartwig Lescow | 13 |
| Aygül Özkan | 12 |
| Florian Kawohl | 12 |
| Tim Funnell | 10 |
| Kieran Mudryy | 10 |
| Martin Ostermayer | 10 |
| Abhinav Shukla | 9 |
| Philippe Fauchet | 9 |
- Borsa valori
- Insiders
- Andrey Kozlov
- Connessioni Società
